SCHEMBL1480780

SCHEMBL1480780

CCn1cc(-c2ccc(Cl)cc2Cl)nc1/C=C/c1ccc(OC)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 2/20 0.42
AHR P35869 1/20 0.42
CXCR2 P25025 1/20 0.41
DPP4 P27487 3/20 0.41
DPP8 Q6V1X1 2/20 0.41
DPP9 Q86TI2 2/20 0.41
MAPT P10636 4/20 0.39
LMNA P02545 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FLT3 P36888 4/20 0.38
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
CDK5 Q00535 1/20 0.37
PAX8 Q06710 1/20 0.37
CDK5R1 Q15078 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1480782 1.00 RELA (0.42) RELAAHRCXCR2DPP4DPP8
SCHEMBL1480190 0.97 DPP4 (0.43) RELAAHRCXCR2DPP4DPP8
SCHEMBL1480187 0.97 DPP4 (0.43) RELAAHRCXCR2DPP4DPP8
SCHEMBL1481166 0.94 RELA (0.38) RELAAHRCXCR2DPP4DPP8
SCHEMBL1481164 0.94 RELA (0.38) RELAAHRCXCR2DPP4DPP8
SCHEMBL1481743 0.90 TLR8 (0.43) RELAAHRCXCR2DPP4DPP8
SCHEMBL1481741 0.90 TLR8 (0.43) RELAAHRCXCR2DPP4DPP8
SCHEMBL1480852 0.89 DPP4 (0.42) RELAAHRCXCR2DPP4DPP8
SCHEMBL1480849 0.89 DPP4 (0.42) RELAAHRCXCR2DPP4DPP8
SCHEMBL1481462 0.89 RELA (0.40) RELAAHRCXCR2DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 US disclosed
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 US disclosed
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 US disclosed
US-20040192743-A1 Substituted azole derivatives as therapeutic agents TRANSTECH PHARMA, INC. 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192743-A1 Substituted azole derivatives as therapeutic agents PTPRS, PTPRO, PTPRJ RELA 3971/4885AHR 1771/4885CXCR2 2203/4885
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents PTPRS, PTPRO, PTPRJ RELA 3971/4885AHR 1771/4885CXCR2 2203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.